Date | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities | Dividends Paid | Capital Expenditure |
---|
CEO | Mr. Nicholas T. Curtis |
IPO Date | Oct. 2, 2020 |
Location | United States |
Headquarters | 2800 Discovery Drive |
Employees | 130 |
Sector | Consumer Discretionary |
Industries |
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Past 5 years
USD 1.64
USD 18.20
USD 13.61
USD 2.73
USD 2.83
USD 17.92
USD 34.07
USD 33.70
USD 9.69
USD 5.84
StockViz Staff
February 4, 2025
Any question? Send us an email